Jacqueline Vo
Expertise in
11
conditions

Dr. Jacqueline Vo

Rheumatology
2204 Austin St, Ste 200, 
Houston, TX 
Offers Telehealth
28 Years of Experience
Expertise in
11
conditions
2204 Austin St, Ste 200, 
Houston, TX 

Overview

Dr. Jacqueline Vo grew up in Ohio and earned her medical degree at Northeast Ohio College of Medicine. She completed her internship and residency in internal medicine at Riverside Methodist Hospital in Columbus, Ohio, and her fellowship in rheumatology at the University of Illinois in Chicago. Dr. Vo, who has been in practice since 1998, is board certified in rheumatology. She treats adult patients (18 and older) and speaks Vietnamese. Her primary clinical interests are rheumatoid arthritis, psoriatic arthritis, osteoarthritis and systemic lupus erythematosus. Her office has an onsite infusion suite that is fully equipped to deliver up-to-date infusion medications to patients with arthritis and connective tissue diseases. A thorough and compassionate physician, Dr. Vo spends a lot of time with her patients. She strongly believes in patient education and encourages them to take an active and responsible role in their health care. She is a member of the American College of Rheumatology, American Medical Association and Vietnamese American Medical Association. Dr. Vo, who lives in Houston, is married and the mother of four children. Away from her practice, her favorite activities are spending time with her family, exercising, cooking, drawing and photography.

Dr. Vo is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Rheumatoid Arthritis (RA), Fibromyalgia, Psoriasis, and Sjogren Syndrome.

She is actively involved in clinical research, participating in 9 clinical trials.

Graduate Institution

Northeastern Ohio Universities College Of Medicine-Registrar, 1998

Residency

Riverside Methodist Hospitals

Specialties

Rheumatology

Licenses

Internal Medicine in TX

Fellowships

University of Illinois at Chicago - Rheumatology 2003

Hospital Affiliations

Memorial Hermann Pearland Hospital
Memorial Hermann Southeast Hospital

Languages Spoken

English
Vietnamese

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
SelectHealth
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

2204 Austin St, Ste 200, Houston, TX 77002
Other Locations
10907 Memorial Hermann Dr, Ste 300, Pearland, TX 77584

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Two-Arm, Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of LY3361237 as a Treatment for Adults With At Least Moderately Active Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Drug
Study Drug: LY3361237
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: July 23, 2024
Intervention Type: Drug, Other
Study Drug: VIB7734
Study Phase: Phase 2
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. John Reveille
Rheumatology
Expertise in
10
conditions
Dr. John Reveille
Rheumatology
Referral may be required
6410 Fannin St, Ste 450, 
Houston, TX 
 (0.9 miles away)
832-325-7191
Experience:
49+ years
Languages Spoken:
English, Spanish
See accepted insurances

John Reveille is a Rheumatologist practicing medicine in Houston, Texas. He has been practicing medicine for over 49 years. Dr. Reveille is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Ankylosing Spondylitis, Arthritis, Axial Spondyloarthritis (AxSpA), and Scleroderma.

Expertise in
8
conditions
Dr. Shervin Assassi
Rheumatology
Expertise in
8
conditions
Dr. Shervin Assassi
Rheumatology
Referral required
6410 Fannin St, Ste 450, 
Houston, TX 
 (0.9 miles away)
713-486-3100
Experience:
27+ years
Languages Spoken:
English, Farsi
See accepted insurances

Shervin Assassi is a Rheumatologist practicing medicine in Houston, Texas. He has been practicing medicine for over 27 years. Dr. Assassi is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Localized Scleroderma, and Ankylosing Spondylitis.

Expertise in
7
conditions
Dr. Eleni Tiniakou
Rheumatology
Expertise in
7
conditions
Dr. Eleni Tiniakou
Rheumatology
Referral may be required
6410 Fannin St, Ste 450, 
Houston, TX 
 (0.9 miles away)
713-486-3100
Experience:
20+ years
Languages Spoken:
English, German, Greek
See accepted insurances
Offers Telehealth

Eleni Tiniakou is a Rheumatologist practicing medicine in Houston, Texas. She has been practicing medicine for over 20 years. Dr. Tiniakou is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Necrotizing Myopathy (NM).

Frequently Asked Questions about Dr. Jacqueline Vo

How do I make an appointment with Dr. Jacqueline Vo?

You can book an appointment with Dr. Jacqueline Vo by calling their office at 713-640-5477. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jacqueline Vo a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jacqueline Vo is classified as an Advanced expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jacqueline Vo specialize in?

While Dr. Jacqueline Vo is a Rheumatology, they have specific expertise in Rheumatoid Arthritis (RA), Fibromyalgia, and Psoriasis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Rheumatology.

Does Dr. Jacqueline Vo accept my insurance?

Dr. Jacqueline Vo accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-640-5477 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Vo's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 45 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile